Overview

Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether 1000 micrograms of self-administered vaginal misoprostol 12 hours before operative hysteroscopy results in effective preoperative cervical ripening after two weeks pretreatment with 25 micrograms daily vaginal estradiol, compared to placebo (lactosum monohydricum) in postmenopausal women.
Phase:
Phase 3
Details
Lead Sponsor:
Ullevaal University Hospital
Collaborator:
Helse Nord
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Misoprostol
Polyestradiol phosphate